Requirement for Ras/Raf/ERK pathway in naringin-induced G1 -cell-cycle arrest via p21WAF1 expression

Carcinogenesis

Volumn 29, Issue 9, 2008, Pages 1701-1709

  Kim, Dong Il ^a   Lee, Se Jung ^a   Lee, Soo Bok ^b   Park, Keerang ^c   Kim, Wun Jae ^d   Moon, Sung Kwon ^a  

^a Chungju National University   (South Korea)

^b Yonsei University   (South Korea)

^c Juseong College   (South Korea)

^d Chungbuk National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AURANTIIN; CELL CYCLE PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

CELL PROLIFERATION; CELLS, CULTURED; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FIBROBLASTS; FLAVANONES; G1 PHASE; GENES, DOMINANT; HUMANS; IMMUNOPRECIPITATION; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; ONCOGENE PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-RAF; PROTO-ONCOGENE PROTEINS P21(RAS); RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; URINARY BLADDER NEOPLASMS;

EID: 51849143663     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn055     Document Type: Article

References (46)

1. Benhamou,S. et al. (2003) DNA adducts in normal bladder tissue and bladder cancer risk. Mutagenesis, 18, 445-448.
2. Friedel,G.H. et al. (1983) In Bryan,G.T. and Cohen,S.M. (eds.) The Pathology of Bladder Cancer, Vol. I, CRC Press, Inc, Boca Raton, FL, pp. 11-42.
3. Pauli,B.U. et al. (1983) In Bryan,G.T. and Cohen,S.M. (eds.) The Pathology of Bladder Cancer, Vol. II, CRC Press, Inc, Boca Raton, FL, pp. 41-140.
4. Levi,F. et al. (1993) Incidence of infiltrating cancer following superficial bladder carcinoma. Int. J. Cancer, 55, 419-554.
5. El-Deiry,W.S. et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
6. Harper,J.W. et al. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816.
7. Harper,J.W. et al. (1995) Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell, 6, 387-400.
8. Lee,C.H. et al. (2001) Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biochem. Biophys. Res. Commun., 284, 681-688.
9. Kaul,T.N. et al. (1985) Antiviral effect of flavonoids on human viruses. J. Med. Virol., 15, 71-79.
10. Morgan,D.O. (1995) Principles of CDK regulation. Nature, 374 131-134.
11. Davis,R.J. (1993) The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem., 268, 14553-14556.
12. Karin,M. et al. (1995) Transcriptional control by protein phosphorylation: Signal transmission from the cell surface to the nucleus. Curr Biol., 5, 747-757.
13. Cobb,M. et al. (1995) How MAP kinases are regulated? J. Biol. Chem., 270, 14843-14846.
14. Wang,X. et al. (1998) The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem. J., 333, 291-300.
15. Xia,Z. et al. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270, 1326-1331.
16. Boulton,T.G. et al. (1991) ERKs: A family of protein-serine/ threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell, 65, 663-675.
17. Segal,R. et al. (1996) Intracellular signaling pathways activated by neurotrophic factors. Annu. Rev. Neurosci., 19, 463-489.
18. Rundén,E. et al. (1998) Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: Evidence for a MAP kinase-dependent mechanism. J. Neurosci. 18, 7296-7305.
19. Lee,E.R. et al. (2005) Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. J. Biol. Chem., 280, 31498-31507.
20. Park,J.I. et al. (2003) The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway. Mol. Cell. Biol., 23, 543-554.
21. Han,M. et al. (1993) C. elegans lin-45 raf gene participates in let-60 ras-stimulated vulval differentiation. Nature, 363 133-139.
22. Nishida,Y. et al. (1998) Proliferation of both somatic and germ cells is affected in the Drosophila mutants of raf proto-oncogene. EMBO. J., 7, 775-781.
23. Hsu,Y.F. et al. (2007) Involvement of Ras/Raf-1/ERK actions in the magnolol-induced upregulation of p21 and cell-cycle arrest in colon cancer cells. Mol. Carcinog., 46, 275-283.
24. Ng,T.B. et al. (2000) Antioxidative activity of natural products from plants. Life Sci., 66, 709-723.
25. Ueng,Y.F. et al. (1999) In vitro and in vivo effects of naringin on cytochrome P450-dependent monooxygenase in mouse liver. Life Sci., 65, 2591-2602.
26. So,F.V. et al. (1996) Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr. Cancer, 26, 167-181.
27. Le Marchand,L. et al. (2000) Intake of flavonoids and lung cancer. J. Natl Cancer Inst., 92, 154-160.
28. Kanno,S. et al. (2005) Inhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice. Biol. Pharm. Bull., 28, 527-530.
29. Huang,Y. et al. (2005) Role of p53/p21(Waf1/Cip1) in the regulation of polyamine analogue-induced growth inhibition and cell death in human breast cancer cells. Cancer Biol. Ther., 4, 1006-1013.
30. Moon,S.K. et al. (2004) PDTC, metal chelating compound, induces G1 phase cell cycle arrest in vascular smooth muscle cells through inducing p21Cip1 expression: Involvement of p38 mitogen activated protein kinase. J. Cell. Physiol., 198, 310-323.
31. Moon,S.K. et al. (2004) Disialoganglioside (GD3) synthase gene expression suppresses vascular smooth muscle cell responses via the inhibition of ERK1/2 phosphorylation, cell cycle progression, and matrix metalloproteinase-9 expression. J. Biol. Chem., 279, 33063-33070.
32. El-Deiry,W.S. et al. (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res., 54, 1169-1174.
33. Datto,M.B. et al. (1995) Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem., 270, 28623-28628.
34. Moon,S.K. et al. (2004) ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway. J. Cell. Physiol., 198, 417-427.
35. Macleod,K.F. et al. (1995) p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev., 9, 935-939.
36. Hu,P.P. et al. (1999) The MEK pathway is required for stimulation of p21(WAF1/CIP1) by transforming growth factor-beta. J. Biol. Chem. 274, 35381-35387.
37. Blenis,J. (1993) Signal transduction via the MAP kinases: Proceed at your own RSK. Proc. Natl Acad. Sci. USA, 90, 5889-5892.
38. Blumer,K.L. et al. (1994) Diversity in function and regulation of MAP kinase pathways. Trends Biochem. Sci., 19, 236-240.
39. Post,G.R. et al. (1996) G protein-coupled receptors and signaling pathways regulating growth responses. FASEB J., 10, 741-749.
40. Lavoie,J.N. et al. (1996) Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem., 271, 20608-20616.
41. Lee,B. et al. (2006) Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells. FEBS Lett. 580, 5177-5184.
42. Marshall,C. (1999) How do small GTPase signal transduction pathways regulate cell cycle entry? Curr. Opin. Cell Biol., 11, 732-736.
43. Genersch,E. et al. (2000) Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J. Cell Sci. 23, 4319-4330.
44. Auer,K.L. et al. (1998) The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes. Mol. Biol. Cell, 9 b, 561-573.
45. Fanton,C.P. et al. (2001) Dual growth arrest pathways in astrocytes and astrocytic tumors in response to Raf-1 activation. J. Biol. Chem., 276, 18871-18877.
46. Malumbres,M. et al. (2000) Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b). Mol. Cell. Biol., 20, 2915-2925.